Recipharm

Meribel Pharma Solutions Launches

A new, mid-size Contract Development Manufacturing Organisation (CDMO), Meribel Pharma Solutions, has launched today with an extensive integrated network across Europe.

The Evolution of the CDMO Industry

The evolution of the CDMO sector is propelled by rising manufacturing standards, the advent of groundbreaking therapies, and a shift towards personalized medicine. CHEManager asked executives and industry experts from a broad range of CDMOs to share their views on how their companies are dealing with this changing economic environment and the resulting opportunities and challenges.

Expert Statement: Greg Behar, Recipharm

The evolution of the CDMO sector is propelled by rising manufacturing standards, the advent of groundbreaking therapies, and a shift towards personalized medicine.

Recipharm Bolsters Blow-Fill-Seal Capabilities in France

Swedish multinational CDMO Recipharm has bolstered its sterile filling capabilities at its facility in Kaysersberg, France, by installing Lab+ continuous automated technology.

Recipharm Buys US CDMO Arranta Bio

Sweden’s Recipharm is acquiring US CDMO Arranta Bio for an undisclosed sum. The deal, expected to close around the end of March, establishes a strong US presence for Recipharm and provides a further platform for building capabilities in new biologics molecules.

Recipharm Divests Sites in France and the UK

Over the course of January, Swedish CDMO Recipharm has sold two of its manufacturing sites to two different buyers in two different countries. One of the divested sites is at Fontaine-lès-Dijon, France, and the other in Newcastle, UK.

Recipharm Expands Israel Capacity

Swedish CDMO Recipharm is investing in a capacity expansion at its facility located south of Tel Aviv in Israel, in order to support growing demand for cGMP clinical supply of APIs and intermediates.

Expert Interview: Mark Quick, Recipharm

So far, the pharmaceutical industry — including CMOs/CDMOs and CROs — has responded well to the outbreak of the Covid-19 pandemic. However, the coronavirus crisis has uncovered problems that have been smoldering beneath the surface and need to be addressed. That supply chains are vulnerable to disruption when major development, production and transportation hubs are blocked or shut down has become painfully obvious.

A Wide Spectrum of Contract Services

Recipharm Works to Soften Brexit Impact

Bernard Pluta Appointed as President of Recipharm’s Development Services

Henrik Stenqvist Becomes Recipharm's New CFO

Recipharm Lifts Italian Lyophilization Capacity

Recipharm Buys Three Kemwell Businesses

Recipharm Acquires Italy’s Mitim

Recipharm in Ophthalmic Collaboration with Alcon

Recipharm Extends Erdosteine API Pact with Daewoong

Recipharm to Take Majority of Indian Firm

Recipharm Appoints New Sales Director, Development Services

Recipharm Completes Acquisition of OnTarget

Recipharm Appoints Chief Strategy Officer

Dr. Giorgio Bruno Appointed as New General Manager of Recipharm Italia

Recipharm Buys Synthonics Preferred Stock

Recipharm Appoints Thomas Beck as Vice President Quality Management

Recipharm Delivers Complex Serialization Project for China

Recipharm and Isofol Medical in Exclusive Drug Development

Recipharm and CTC in Clinical Trial Collaboration

Swedish Drug Maker Recipharm Looks to List or Sell Stake

Recipharm Site Approved for Supply of Manufactured Products to Japan

Recipharm Appoints Hans Lennernäs to Operating Board

Recipharm, Astimex to Collaborate on Development and Manufacturing